Android
Nokia
Windows
Published on Thu, Jan 28, 2010 at 15:15 | Source : CNBC-TV18
Updated at Fri, Jan 29, 2010 at 11:15
ALSO READ
Dishman Pharma
BSE | NSE 31/05/12
Dishman Pharma has declared its third quarter results. The company's Q3 consolidated net profit was down at Rs 33.1 crore versus Rs 39.6 crore.
Its consolidated net sales were up at Rs 222 crore versus Rs 282 crore.
The company's trailing 12-month (TTM) EPS was at Rs 9.95 per share. (Sep, 2009) The stock's price-to-earnings (P/E) ratio stands at 22.73.
PREVIOUS STORY
Buy Ramky Infra; target of Rs 353: AnandRathi
NEXT STORY
Morgan Stanley gets RBI nod for banking licence
Bharat Bandh hits normal life in several states
Prakash Javadekar CNBC-TV18 Exclusive Will Be Happy If A Probe In The Matter Has Been Ordered
May 31 2012, 20:34
Euro headed towards 1.20, says Lloyds TSB`s Trevor Williams
- in FII View
May 31 2012, 12:15
Economic data will dictate how US market moves: Solaris AMC
May 31 2012, 17:09 | Source: CNBC-TV18
Eyeing 5-6% growth in tractor segment during FY13: M&M
May 31 2012, 14:55 | Source: CNBC-TV18
Expect reasonable growth in profits ahead: Praj Industries
Subscribe to
Moneycontrol Newsletters
Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!
